The largest leishmaniasis outbreak in Europe was declared since June 2009 in Fuenlabrada (Madrid, Spain). Our aim was to estimate the prevalence of asymptomatic Leishmania infection in the HIV cohort of Fuenlabrada, in this high exposure setting, and analyze the risk factors for the development of visceral leishmaniasis.
A representative sample of the Fuenlabrada’s HIV cohort was selected for exposure test to Leishmania. An infected patient was defined as a positive result in, at least, one of following blood tests for Leishmania: PCR, serology (ELISA or IFAT) or SLA (stimulation to Leishmania antigen) lymphoproliferative test as marker of cellular immunity. Infected vs not infected patients, and visceral leishmaniasis vs asymptomatic infected patients, were analyzed with statistical tests looking for risk factors. This work has been supported by ‘Red de Investigación Cooperativa en Enfermedades Tropicales’ (RICET + RD12/0018/0008), VI PN de I + D + I 2008–2011, ISCIII- Subdirección General de Redes y Centros de Investigación Cooperativa; and fondos FEDER
583 patients of the Fuenlabrada’s HIV cohort were followed since 1st June 2004 to 31th December 2015. 135 representative patients were selected for exposure test to Leishmania, including 12 symptomatic patients (10 visceral and 2 cutaneous). 19 (15.4%) of the 123 asymptomatic patients fulfilled the definition for Leishmania infection, none of them became symptomatic during the study period. Total prevalence of the cohort was estimated 17.5%. Multivariate analysis was performed in infected vs not infected patients and find association to the ‘distance to Bosquesur park’, considered the focus of the outbreak, 1082 meters media distance to the park in infected vs 1719 meters not infected (ANOVA p=0.02). Multivariate analysis performed between patients who developed visceral leishmaniasis vs asymptomatic patients showed association to illness development only for patients with ‘negative SLA test with positive PCR or serology’ (p<0,001, OR not calculable) and ‘less than 100 CD4 during outbreak period’ (p=0,001, OR not calculable).
In the TARGA era, 15.4% of our HIV cohort has been infected by Leishmania, but are asymptomatic. Negative SLA test with positive PCR or serology, reflects the absence of specific immune response to Leishmania, and is therefore an independent risk factor for visceral leishmaniasis